一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Mediators of Inflammation >>article
Mediators of Inflammation

Mediators of Inflammation

IF: 4.4
Download PDF

Mechanism of action of 5-arninosalicylic acid.

Published:1 January 1992 DOI: 10.1155/S0962935192000243 PMID: 18475455
N A Punchard, S M Greenfield, R P Thompson

Abstract

5-Aminosalicylic Acid (5-ASA) has been used for over 50 years in the treatment of inflammatory bowel disease in the pro-drug form sulphasalazine (SASP). SASP is also used to treat rheumatoid arthritis. However whether the therapeutic properties of SASP are due to the intact molecule, the 5-ASA or sulphapyridine components is unknown. Several mechanisms of action have been proposed for 5-ASA and SASP including interference in the metabolism of arachidonic acid to prostaglandins and leukotrienes, scavenging,of reactive oxygen species, effects on leucocyte function and production of cytokines. However, it is unlikely that the anti-inflammatory properties of SASP and 5-ASA are due to several different properties but more likely that a single property of 5-ASA explains the theraapeutic effects of 5-ASA and SASP. Reactive oxygen species (ROS) are involved in the metabolism of prostaglandins and leukotrienes and can act as second messengers, and so the scavenging of ROS may be the single mechanism of action of 5-ASA that gives rise to its antiinflammatory effects in both inflammatory bowel disease and rheumatoid arthritis.

Substances (5)

Related products
Procduct Name CAS Molecular Formula Supplier Price
5-Aminosalicylic acid 89-57-6 C7H7NO3 957 suppliers $5.00-$1880.00
Sulfasalazine 599-79-1 C18H14N4O5S 475 suppliers $7.00-$690.00
Sulfapyridine 144-83-2 C11H11N3O2S 427 suppliers $5.00-$1880.00
ROS 37 suppliers Inquiry
Reactive Oxygen Species 1 suppliers Inquiry

Similar articles

IF:6.6

Review article: mode of action and delivery of 5-aminosalicylic acid – new evidence

Alimentary Pharmacology & Therapeutics P. DESREUMAUX, S. GHOSH,etc Published: 22 August 2006
IF:2.6

Ezetimibe therapy: mechanism of action and clinical update.

Vascular Health and Risk Management Binh An P Phan,?Thomas D Dayspring,etc Published: 1 January 2012
IF:72.5

5-Fluorouracil: mechanisms of action and clinical strategies

Nature Reviews Cancer Daniel B. Longley, D. Paul Harkin,etc Published: 1 May 2003
依兰县| 云林县| 安远县| 资兴市| 兴义市| 灵宝市| 怀仁县| 柳州市| 塘沽区| 宜阳县| 商南县| 宣武区| 获嘉县| 安仁县| 镇远县| 馆陶县| 义乌市| 富宁县| 仁怀市| 武强县| 胶州市| 巨野县| 得荣县| 吉安县| 申扎县| 广水市| 仙居县| 闵行区| 定州市| 鲜城| 库尔勒市| 青冈县| 天水市| 陆良县| 嘉荫县| 新源县| 咸宁市| 嘉义县| 龙游县| 蒙阴县| 阜康市|